CD4 and anal carcinoma: Moreover, the combination of HPV16 L1 gene hypermethylation together with a low CD4 count in HIV-infected patients might be used as a biomarker for rapid progression to more severe lesions and anal cancer than those with a low methylation and high CD4 count.